Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients

Cell Reports

Volumn 16, Issue 3, 2016, Pages 631-643

  Semenova, Ekaterina A ^a   Kwon, Min chul ^a   Monkhorst, Kim ^a   Song, Ji Ying ^a   Bhaskaran, Rajith ^a   Krijgsman, Oscar ^a   Kuilman, Thomas ^a   Peters, Dennis ^a   Buikhuisen, Wieneke A ^a   Smit, Egbert F ^a   Pritchard, Colin ^a   Cozijnsen, Miranda ^a   van der Vliet, Jan ^a   Zevenhoven, John ^a   Lambooij, Jan Paul ^a   Proost, Natalie ^a   van Montfort, Erwin ^a   Velds, Arno ^a   Huijbers, Ivo J ^a   Berns, Anton ^a,b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b SKOLKOVO INSTITUTE OF SCIENCE AND TECHNOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFIB; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; MYC PROTEIN; NFIB PROTEIN, HUMAN; NFIB PROTEIN, MOUSE; NUCLEAR FACTOR I; PROTEIN P53; RETINOBLASTOMA PROTEIN; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METASTASIS; CANCER GROWTH; CELL DEDIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL POPULATION; CELL SURVIVAL; CHROMOSOMAL INSTABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; GENE OVEREXPRESSION; HUMAN; IN VIVO STUDY; KIDNEY METASTASIS; METASTASIS; MOUSE; MOUSE MODEL; NONHUMAN; ONCOGENESIS AND MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; SMALL CELL LUNG CANCER; TUMOR INITIATION; ANIMAL; CELL PROLIFERATION; DISEASE EXACERBATION; DISEASE MODEL; GENE EXPRESSION REGULATION; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BIOMARKERS, TUMOR; CADHERINS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; NEOPLASM METASTASIS; NFI TRANSCRIPTION FACTORS; PROTO-ONCOGENE PROTEINS C-MYC; RETINOBLASTOMA PROTEIN; SMALL CELL LUNG CARCINOMA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84978388629     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.06.020     Document Type: Article

References (43)

1. Andreasen, S., Persson, M., Kiss, K., Homøe, P., Heegaard, S., Stenman, G., Genomic profiling of a combined large cell neuroendocrine carcinoma of the submandibular gland. Oncol. Rep. 35 (2016), 2177–2182.
2. Augustyn, A., Borromeo, M., Wang, T., Fujimoto, J., Shao, C., Dospoy, P.D., Lee, V., Tan, C., Sullivan, J.P., Larsen, J.E., et al. ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers. Proc. Natl. Acad. Sci. USA 111 (2014), 14788–14793.
3. Byers, L.A., Rudin, C.M., Small cell lung cancer: where do we go from here?. Cancer 121 (2015), 664–672.
4. Calbo, J., van Montfort, E., Proost, N., van Drunen, E., Beverloo, H.B., Meuwissen, R., Berns, A., A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer. Cancer Cell 19 (2011), 244–256.
5. Cermáková, K., Tesina, P., Demeulemeester, J., El Ashkar, S., Méreau, H., Schwaller, J., Rezáčová, P., Veverka, V., De Rijck, J., Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia. Cancer Res. 74 (2014), 5139–5151.
6. Chang, C.Y., Pasolli, H.A., Giannopoulou, E.G., Guasch, G., Gronostajski, R.M., Elemento, O., Fuchs, E., NFIB is a governor of epithelial-melanocyte stem cell behaviour in a shared niche. Nature 495 (2013), 98–102.
7. Dooley, A.L., Winslow, M.M., Chiang, D.Y., Banerji, S., Stransky, N., Dayton, T.L., Snyder, E.L., Senna, S., Whittaker, C.A., Bronson, R.T., et al. Nuclear factor I/B is an oncogene in small cell lung cancer. Genes Dev. 25 (2011), 1470–1475.
8. Ellenbroek, S.I., Iden, S., Collard, J.G., Cell polarity proteins and cancer. Semin. Cancer Biol. 22 (2012), 208–215.
9. French, J.D., Johnatty, S.E., Lu, Y., Beesley, J., Gao, B., Kalimutho, M., Henderson, M.J., Russell, A.J., Kar, S., Chen, X., et al. On Behalf Of The Ovarian Cancer Association Consortium Australian Ovarian Cancer Study Group, Australian Ovarian Cancer Study. Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer. Oncotarget 7 (2016), 6353–6368.
10. Gazdar, A.F., Savage, T.K., Johnson, J.E., Berns, A., Sage, J., Linnoila, R.I., MacPherson, D., McFadden, D.G., Farago, A., Jacks, T., et al. The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung. J. Thorac. Oncol. 10 (2015), 553–564.
11. George, J., Lim, J.S., Jang, S.J., Cun, Y., Ozretić, L., Kong, G., Leenders, F., Lu, X., Fernández-Cuesta, L., Bosco, G., et al. Comprehensive genomic profiles of small cell lung cancer. Nature 524 (2015), 47–53.
12. Ghanem, G., Fabrice, J., Tyrosinase related protein 1 (TYRP1/gp75) in human cutaneous melanoma. Mol. Oncol. 5 (2011), 150–155.
13. Gronostajski, R.M., Roles of the NFI/CTF gene family in transcription and development. Gene 249 (2000), 31–45.
14. Han, W., Jung, E.M., Cho, J., Lee, J.W., Hwang, K.T., Yang, S.J., Kang, J.J., Bae, J.Y., Jeon, Y.K., Park, I.A., et al. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer. Genes Chromosomes Cancer 47 (2008), 490–499.
15. Harris, L., Genovesi, L.A., Gronostajski, R.M., Wainwright, B.J., Piper, M., Nuclear factor one transcription factors: divergent functions in developmental versus adult stem cell populations. Dev. Dyn. 244 (2015), 227–238.
16. Holm, P.C., Mader, M.T., Haubst, N., Wizenmann, A., Sigvardsson, M., Götz, M., Loss- and gain-of-function analyses reveal targets of Pax6 in the developing mouse telencephalon. Mol. Cell. Neurosci. 34 (2007), 99–119.
17. Hsu, Y.C., Osinski, J., Campbell, C.E., Litwack, E.D., Wang, D., Liu, S., Bachurski, C.J., Gronostajski, R.M., Mesenchymal nuclear factor I B regulates cell proliferation and epithelial differentiation during lung maturation. Dev. Biol. 354 (2011), 242–252.
18. Huijbers, I.J., Bin Ali, R., Pritchard, C., Cozijnsen, M., Kwon, M.C., Proost, N., Song, J.Y., de Vries, H., Badhai, J., Sutherland, K., et al. Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells. EMBO Mol. Med. 6 (2014), 212–225.
19. Huijbers, I.J., Del Bravo, J., Bin Ali, R., Pritchard, C., Braumuller, T.M., van Miltenburg, M.H., Henneman, L., Michalak, E.M., Berns, A., Jonkers, J., Using the GEMM-ESC strategy to study gene function in mouse models. Nat. Protoc. 10 (2015), 1755–1785.
20. Iwakawa, R., Takenaka, M., Kohno, T., Shimada, Y., Totoki, Y., Shibata, T., Tsuta, K., Nishikawa, R., Noguchi, M., Sato-Otsubo, A., et al. Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer. Genes Chromosomes Cancer 52 (2013), 802–816.
21. Kuilman, T., Velds, A., Kemper, K., Ranzani, M., Bombardelli, L., Hoogstraat, M., Nevedomskaya, E., Xu, G., de Ruiter, J., Lolkema, M.P., et al. CopywriteR: DNA copy number detection from off-target sequence data. Genome Biol., 16, 2015, 49.
22. Kwon, M.C., Berns, A., Mouse models for lung cancer. Mol. Oncol. 7 (2013), 165–177.
23. Kwon, M.C., Proost, N., Song, J.Y., Sutherland, K.D., Zevenhoven, J., Berns, A., Paracrine signaling between tumor subclones of mouse SCLC: a critical role of ETS transcription factor Pea3 in facilitating metastasis. Genes Dev. 29 (2015), 1587–1592.
24. Liu, Y., Bernard, H.U., Apt, D., NFI-B3, a novel transcriptional repressor of the nuclear factor I family, is generated by alternative RNA processing. J. Biol. Chem. 272 (1997), 10739–10745.
25. McFadden, D.G., Papagiannakopoulos, T., Taylor-Weiner, A., Stewart, C., Carter, S.L., Cibulskis, K., Bhutkar, A., McKenna, A., Dooley, A., Vernon, A., et al. Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing. Cell 156 (2014), 1298–1311.
26. Mermod, N., O'Neill, E.A., Kelly, T.J., Tjian, R., The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain. Cell 58 (1989), 741–753.
27. Meuwissen, R., Linn, S.C., Linnoila, R.I., Zevenhoven, J., Mooi, W.J., Berns, A., Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 4 (2003), 181–189.
28. Mosakhani, N., Pazzaglia, L., Benassi, M.S., Borze, I., Quattrini, I., Picci, P., Knuutila, S., MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone. Histol. Histopathol. 28 (2013), 671–678.
29. Ninkovic, J., Steiner-Mezzadri, A., Jawerka, M., Akinci, U., Masserdotti, G., Petricca, S., Fischer, J., von Holst, A., Beckers, J., Lie, C.D., et al. The BAF complex interacts with Pax6 in adult neural progenitors to establish a neurogenic cross-regulatory transcriptional network. Cell Stem Cell 13 (2013), 403–418.
30. Piper, M., Barry, G., Harvey, T.J., McLeay, R., Smith, A.G., Harris, L., Mason, S., Stringer, B.W., Day, B.W., Wray, N.R., et al. NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development. J. Neurosci. 34 (2014), 2921–2930.
31. Quattrini, I., Pollino, S., Pazzaglia, L., Conti, A., Novello, C., Ferrari, C., Pignotti, E., Picci, P., Benassi, M.S., Prognostic role of nuclear factor/IB and bone remodeling proteins in metastatic giant cell tumor of bone: a retrospective study. J. Orthop. Res. 33 (2015), 1205–1211.
32. Rudin, C.M., Durinck, S., Stawiski, E.W., Poirier, J.T., Modrusan, Z., Shames, D.S., Bergbower, E.A., Guan, Y., Shin, J., Guillory, J., et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat. Genet. 44 (2012), 1111–1116.
33. Schneider, M.R., Kolligs, F.T., E-cadherin's role in development, tissue homeostasis and disease: insights from mouse models: tissue-specific inactivation of the adhesion protein E-cadherin in mice reveals its functions in health and disease. BioEssays 37 (2015), 294–304.
34. Semenova, E.A., Nagel, R., Berns, A., Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes Dev. 29 (2015), 1447–1462.
35. Singhai, R., Patil, V.W., Jaiswal, S.R., Patil, S.D., Tayade, M.B., Patil, A.V., E-Cadherin as a diagnostic biomarker in breast cancer. N. Am. J. Med. Sci. 3 (2011), 227–233.
36. Steele-Perkins, G., Plachez, C., Butz, K.G., Yang, G., Bachurski, C.J., Kinsman, S.L., Litwack, E.D., Richards, L.J., Gronostajski, R.M., The transcription factor gene Nfib is essential for both lung maturation and brain development. Mol. Cell. Biol. 25 (2005), 685–698.
37. Stephens, P.J., Greenman, C.D., Fu, B., Yang, F., Bignell, G.R., Mudie, L.J., Pleasance, E.D., Lau, K.W., Beare, D., Stebbings, L.A., et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144 (2011), 27–40.
38. Travis, W.D., Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas. Mod. Pathol. 25:Suppl 1 (2012), S18–S30.
39. Travis, W.D., Brambilla, E., Nicholson, A.G., Yatabe, Y., Austin, J.H., Beasley, M.B., Chirieac, L.R., Dacic, S., Duhig, E., Flieder, D.B., et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J. Thorac. Oncol. 10 (2015), 1243–1260.
40. Tsai, P.C., Bake, S., Balaraman, S., Rawlings, J., Holgate, R.R., Dubois, D., Miranda, R.C., MiR-153 targets the nuclear factor-1 family and protects against teratogenic effects of ethanol exposure in fetal neural stem cells. Biol. Open 3 (2014), 741–758.
41. Wang, Y., Huang, C., Chintagari, N.R., Xi, D., Weng, T., Liu, L., miR-124 regulates fetal pulmonary epithelial cell maturation. Am. J. Physiol. Lung Cell. Mol. Physiol. 309 (2015), L400–L413.
42. Yang, Z.Q., Imoto, I., Pimkhaokham, A., Shimada, Y., Sasaki, K., Oka, M., Inazawa, J., A novel amplicon at 9p23 - 24 in squamous cell carcinoma of the esophagus that lies proximal to GASC1 and harbors NFIB. Jpn. J. Cancer Res. 92 (2001), 423–428.
43. Zhang, Q., Cao, L.Y., Cheng, S.J., Zhang, A.M., Jin, X.S., Li, Y., p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB. Oncol. Rep. 33 (2015), 1335–1341.